Axonics, Inc.: Business Overview, Financials & Competitive Analysis
Axonics, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Specialized neuromodulation leader with validated implantable technology, diversified geographic presence, and growing product portfolio addresses significant unmet clinical needs. Axonics operates in a specialized medical device market with FDA approval and established commercial distribution. The company has secured multiple capital raises and regulatory approvals, demonstrating investor confidence and product validation.
What is Axonics, Inc.'s industry? Axonics, Inc. (axonics.com) operates in Neurostimulation Devices. AskCyborg classifies Axonics, Inc. under Neurostimulation Devices in its company registry.
Axonics is a medical technology company engaged in the development and commercialization of sacral neuromodulation (SNM) systems used to treat patients with overactive bladder, fecal incontinence, and non-obstructive ...
Cyborg Score thesis
Specialized neuromodulation leader with validated implantable technology, diversified geographic presence, and growing product...
Read the full analyst-debate transcript →Get the Latest Axonics, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAxonics, Inc. Overview
Pro stress-test →Axonics is a medical technology company engaged in the development and commercialization of sacral neuromodulation (SNM) systems used to treat patients with overactive bladder, fecal incontinence, and non-obstructive urinary retention. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence.
Strategic Profile
Pro stress-test →The company's proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce symptoms of bladder and bowel dysfunction. Axonics sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally.
Competitive Landscape
Pro stress-test →Axonics competes in the specialized sacral neuromodulation device market alongside established medical device manufacturers. The company's rechargeable implantable technology differentiates it from legacy battery-dependent competitor systems. Main competitors include Medtronic and other neuromodulation device manufacturers offering traditional SNM solutions.
Industry Context
Axonics, Inc. operates in Neurostimulation Devices.
Key facts
Founded: 2013 · Headquarters: Irvine, US · Employees: N/A · Revenue: N/A · Market cap: N/A